CSPC Pharmaceutical Group Limited Forecast, price target & analysts
CSPC Pharmaceutical Group Limited Target price 2024 - Analyst rating & recommendation
CSPC Pharmaceutical Group Limited Classifications & Recommendation:
CSPC Pharmaceutical Group Limited Price Target
| Target Price | HKD6.95 |
| Price | HKD4.75 |
| Potential |
46.32%
register free of charge
|
| Number of Estimates | 24 |
|
24 Analysts have issued a price target CSPC Pharmaceutical Group Limited 2025 .
The average CSPC Pharmaceutical Group Limited target price is HKD6.95.
This is
46.32%
register free of charge
HKD11.89
150.41%
register free of charge
HKD4.60
3.22%
register free of charge
|
|
| A rating was issued by 26 analysts: 16 Analysts recommend CSPC Pharmaceutical Group Limited to buy, 9 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the CSPC Pharmaceutical Group Limited stock has an average upside potential 2025 of
46.32%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Billion HKD | 34.75 | 32.06 |
| 3.40% | 7.74% | |
| EBITDA Margin | 25.80% | 25.18% |
| 1.91% | 2.41% | |
| Net Margin | 18.77% | 17.51% |
| 3.50% | 6.71% |
23 Analysts have issued a sales forecast CSPC Pharmaceutical Group Limited 2024 . The average CSPC Pharmaceutical Group Limited sales estimate is
This results in the following potential growth metrics:
19 Analysts have issued an CSPC Pharmaceutical Group Limited EBITDA forecast 2024. The average CSPC Pharmaceutical Group Limited EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
12 CSPC Pharmaceutical Group Limited Analysts have issued a net profit forecast 2024. The average CSPC Pharmaceutical Group Limited net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share HKD | 0.55 | 0.47 |
| 6.78% | 14.55% | |
| P/E | 10.10 | |
| EV/Sales | 1.43 |
12 Analysts have issued a CSPC Pharmaceutical Group Limited forecast for earnings per share. The average CSPC Pharmaceutical Group Limited <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the CSPC Pharmaceutical Group Limited stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
CSPC Pharmaceutical Group Limited...
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
